PHG vs SNN Stock Comparison

PHG currently leads SNN in this stock comparison, with AIQ scores of 72 vs 70. The clearest difference is momentum, while SNN has the stronger quality profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 2 points
PHG
Healthcare
vs
SNN
Healthcare
PHG
Koninklijke Philips N.V.
Leads
Price
$29.81
Day move
-0.27%
AIQ Score
72/100
Best edge
Momentum
Sector
Healthcare
SNN
Smith & Nephew plc
Price
$30.32
Day move
-0.62%
AIQ Score
70/100
Best edge
Quality
Sector
Healthcare

What is the main difference between PHG and SNN?

PHG leads the current stock comparison as Koninklijke Philips N.V., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Koninklijke Philips N.V. vs Smith & Nephew plc

Data as of Nov 18, 2026· market close· Healthcare· Coverage 61/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

PHG leads

PHG leads by 2 AIQ points, primarily on Momentum.

Fragile: 1 of 5 evidence groups support PHG, and its current signal state is conflicted.

Evidence agreement: 1 of 5Comparison trend: Stable
PHG

Koninklijke Philips N.V.

Leads
AIQ Score
72/100
AIQ Edge Score
10/10
SNN

Smith & Nephew plc

AIQ Score
70/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors PHG over SNN, 72 versus 70 as of Nov 18, 2026. PHG's advantage is driven primarily by stronger momentum, while SNN holds the stronger quality profile. PHG also shows the stronger technical structure relative to its 50-day moving average. 1 of 5 covered evidence groups favor PHG today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. PHG lead: Stable — the AIQ differential has held near 2 points over 30 sessions.

Compare Koninklijke Philips N.V. and Smith & Nephew plc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

PHG
-11.1%
SNN
+2.2%

Total return comparison

Growth of $10,000, distributions reinvested

PHG $8,887 · SNN $10,218

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare PHG and SNN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PHG advantage
0
SNN advantage
  • Momentum72 vs 60
    PHG +12
  • Quality67 vs 73
    SNN +6
  • Risk Resilience73 vs 75
    Even
  • Value80 vs 79
    Even

1 of 5 evidence groups favor PHG. PHG’s edge is concentrated in momentum; SNN keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

PHG0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • RSI Overbought — bearish, momentum, short horizon
SNN0 AIQ

No factor moved materially.

No signal started or stopped since the prior session; its 3 active signals are unchanged.

PHG's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — PHG and SNN both carry a full feed there.

The central trade-off

PHG (Koninklijke Philips N.V.): the stronger current systematic profile, led by momentum.

SNN (Smith & Nephew plc): the counter-case, on quality, fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PHG

PHG on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

SNN

SNN on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

PHG

PHG on the Momentum factor, by 12 points.

Lower downside

Even

Downside measures are level or not covered.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasurePHGSNNNote
Implied upside to target—+11.7%Level
Target dispersion—0%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering56Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

1 of 5 covered evidence groups favor PHG. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven72 vs 70
FundamentalsSNNEPS growth -93.1% vs -7.7%; gross margin 46.4% vs 68.2%; operating margin 10.9% vs 16.7%
ValuationEvenValue 80 vs 79
TechnicalsPHGPrice vs 50-day 14% vs 5.5%; vs 200-day 11.4% vs 1%
Risk ResilienceEvenRisk Resilience 73 vs 75
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PHG and SNN and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
  • Only 1 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PHG.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

PHG lead: Stable — the AIQ differential has held near 2 points over 30 sessions.

Jun 1PHG leads above the line · SNN leads belowNov 18
Today
PHG +2
72 vs 70
7 sessions ago
PHG +2
73 vs 71
30 sessions ago
Level
63 vs 63
90 sessions ago
Level
60 vs 60

The lead changed hands once in this window, most recently on Sep 14 when PHG moved ahead of SNN.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PHGConflicted

3 bullish / 2 bearish / 1 neutral, conflicted

Only PHG

  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
SNN

0 bullish / 2 bearish / 1 neutral

Only SNN

  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 2 more signals that do not separate them: Death Cross Active, ADX Trend Strengthening.

PHG leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PHGNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.27%, AIQ 0 points).

SNNNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.62%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1SNN closes the Momentum gap — currently 12 points behind, the largest single contributor to PHG's edge.
  2. 2SNN's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

SNN leads on balance
MetricPHGSNN
Revenue growth (YoY)0.2%-3.3%
EPS growth (YoY)-93.1%-7.7%
Gross margin46.4%68.2%
Operating margin10.9%16.7%
Return on equity (TTM)0.2%5.8%
Debt to equity0.70.73

Performance

PHG leads 5 of 6 windows
MetricPHGSNN
1 week (5 sessions)0%0.4%
1 month (20 sessions)17.9%7.6%
3 months (63 sessions)13.1%5.4%
6 months (126 sessions)20.3%5.9%
Year to date12%-4.7%
1 year (252 sessions)3.3%-6.5%

Technicals

PHG has the stronger structure
MetricPHGSNN
RSI (14)70.961.4
ADX (14)43.228.9
Price vs 50-day14%5.5%
Price vs 200-day11.4%1%
Volatility (1M, annualized)38.9%38.7%

Risk

Split
MetricPHGSNN
Beta0.850.29
Sharpe ratio0.18-0.2
Sortino ratio0.27-0.29
Max drawdown-27.7%-28.4%
Current drawdown-7.8%-15.2%
Annualized volatility29.7%27.3%
Value at risk (95%)-2.5%-2.8%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PHG or SNN?

On the Algovestiq AIQ Score, PHG is the stronger of the two as of Nov 18, 2026, scoring 72 against SNN's 70. The edge comes from momentum. SNN is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PHG or SNN the better buy right now?

PHG carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 1 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.

Why does the AIQ Score favor PHG over SNN?

The composite weights Quality, Value, Momentum and Risk Resilience. PHG leads Momentum by 12 points; SNN leads Quality by 6 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, PHG or SNN?

Analyst price targets imply not covered upside for PHG and +11.7% for SNN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PHG or SNN?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PHG or SNN?

SNN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PHG or SNN?

PHG on the Momentum factor, by 12 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PHG or SNN?

The two are close on downside measures. Downside measures are level or not covered. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PHG more profitable than SNN?

SNN leads on the comparable margin measures — gross margin 46.4% vs 68.2%; operating margin 10.9% vs 16.7%; ttm roe 0.2% vs 5.8%.

Is PHG's lead over SNN getting stronger or weaker?

PHG lead: Stable — the AIQ differential has held near 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands once in that window, most recently on 2026-09-14, when PHG moved ahead of SNN.

What would change the PHG vs SNN verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SNN closes the Momentum gap — currently 12 points behind, the largest single contributor to PHG's edge; SNN's Death Cross Active resolves — a bearish trend rule currently active against it; PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PHG and SNN?

PHG: 3 bullish / 2 bearish / 1 neutral, conflicted. SNN: 0 bullish / 2 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PHG is Death Cross Active (bearish, long horizon). On SNN it is Death Cross Active (bearish, long horizon).

Compare PHG and SNN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.